Skip to main content Skip to footer

PES NOW INCLUDED IN AHA/ASA STROKE GUIDELINE

Phagenyx
- Clinical Evidence
Healthcare Professionals
- Download Phagenyx Brochure
- Request a Demo
Patients & Families
- FAQ
About Us
- Careers
- News & Events
contact us

Thank you

Thank you for reaching out to Phagenesis. We’ve received your message and look forward to connecting with you.

Phagenyx

Clinical Evidence

Healthcare Professionals

Download Phagenyx Brochure Request a Demo

Patients & Families

About Us

Careers News & Events Contact

Terms of Use

Privacy Policy

Cookies Policy

Manufacturer; Phagenesis Ltd, Enterprise House, Manchester Science Park, Manchester, M15 6SE, UK

Indications for Use (Europe/UK/Switzerland): The Phagenyx System (EPSB3 Base Station and PNX-1000 catheter) is to be used for the treatment of neurogenic dysphagia in adult patients. Phagenyx Safety Information.

Indications for Use (US): Phagenyx is a neurostimulation device delivering electrical stimulation to the oropharynx, to be used in addition to standard dysphagia care, as an aid to improve swallowing in patients with severe dysphagia post stroke.

Federal law in the US restricts this device to sale by or on the order of a physician. Phagenyx Safety Information. The content on this website is intended for healthcare providers and may not be approved for use in your specific region or country. Phagenesis is not responsible for any interactions or dealings you have via this website that do not comply with applicable laws and regulations in your jurisdiction. By continuing to use this website, you acknowledge and agree to the terms of this notice.

© Phagenesis Inc. 2026. All rights reserved. FDA has provided de novo classification for the Phagenyx® System and it is available for sale in the United States. 

© Phagenesis Limited 2026. All rights reserved. The Phagenyx® system is CE marked and is available for sale only in the European Economic Area, UK and Switzerland.

American Heart Association/American Stroke Association 2026 guideline is live!

Pharyngeal Electrical Stimulation (PES) is now recommended.